Cutaneous leishmaniasis in a patient receiving infliximab. [electronic resource]
- Scandinavian journal of infectious diseases Jul 2013
- 567-9 p. digital
Publication Type: Case Reports; Journal Article
1651-1980
10.3109/00365548.2012.752859 doi
Antibodies, Monoclonal--adverse effects Humans Immunosuppressive Agents--adverse effects Infliximab Leishmaniasis, Cutaneous--diagnosis Male Mediterranean Region Middle Aged Steroids--adverse effects